Advertisement
Research Article| Volume 21, ISSUE 5, P867-877, May 1999

Treatment of urge incontinence in veterans affairs medical centers

  • Daniel C. Malone
    Correspondence
    Address correspondence to: Daniel C. Malone, PhD, School of Pharmacy, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Box C-238, Denver, CO 80262-0238.
    Affiliations
    Department of Pharmacy Practice, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado,USA
    Search for articles by this author
  • Author Footnotes
    * At the time of the study, Dr. Okano was a postdoctoral fellow at the School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado.
    Gary J. Okano
    Footnotes
    * At the time of the study, Dr. Okano was a postdoctoral fellow at the School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado.
    Affiliations
    Strategic Outcomes Services, Research Triangle Park, North Carolina, USA
    Search for articles by this author
  • Author Footnotes
    * At the time of the study, Dr. Okano was a postdoctoral fellow at the School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Urinary incontinence has far-reaching medical, psychological, social, and economic effects. The objectives of this descriptive study were to examine utilization patterns and discontinuation rates of various pharmacologic agents used to treat symptoms of overactive bladder, primarily urge incontinence (UI), and to estimate the prevalence of urinary incontinence in the study population. Patient-level data regarding specific drugs used to treat UI and the use of diapers or pads over a 9-month period from October 1995 to May 1996 were retrospectively extracted from the medication databases of 9 Department of Veterans Affairs medical centers. A total of 2233 male patients were included in the analyses. Most patients were receiving oxybutynin chloride (39.8%), dicyclomine hydrochloride (16.0%), or imipramine hydrochloride (13.9%), and the remaining 30.3% were using flavoxate hydrochloride, propantheline bromide, hyoscyamine sulfate, and adult diapers or pads. Overall, 72.1% of patients had been prescribed daily dosages within the recommended dosing ranges for these medications. The majority (91.3%) of patients had not switched to another UI medication during the study period. Based on a chronic disease index, 47.6% of patients had 2 or fewer chronic diseases. Using pooled prevalence estimates, the estimated percentage of patients who had ever experienced UI in this population ranged from 7.4% to 20.8%; however, a considerably smaller percentage were taking medications for the treatment of UI. The results of this study suggest that oxybutynin, dicyclomine, and imipramine are the agents most commonly used to treat urinary incontinence within Veterans Affairs medical centers. The majority of patients who received a prescription for one of these drugs did not routinely refill the medication over the course of the study. There are many reasons for patients not to refill a prescription (eg, ineffectiveness, side effects, complications, obtaining the drug from another source), but the present study did not address the causes.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • National Institutes of Health Consensus Development Conference
        Urinary incontinence in adults.
        J Am Geriatr Soc. 1990; 38: 265-272
        • Ouslander JG
        Urinary incontinence in nursing homes.
        J Am Geriatr Soc. 1990; 38: 289-291
        • Wyman JF
        • Harkins SW
        • Fantl JA
        Psychological impact of urinary incontinence in the community-dwelling population.
        J Am Geriatr Soc. 1990; 38: 282-288
        • Fantl JA
        • Newman DK
        • Colling J
        • et al.
        Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guidelines, No. 2, 1996, Update.
        US Agency for Health Care Policy and Research Publication No. 96-0682. March 1996; (Rockville, Md)
        • Rousseau P
        • Fuentevilla-Clifton A
        Urinary incontinence in the aged. Part 1: Patient evaluation.
        Geriatrics. 1992; 47: 22-34
        • Hampel C
        • Weinhold D
        • Benken N
        • et al.
        Definition of overactive bladder and epidemiology of urinary incontinence.
        Urology. 1997; 50: 4-14
        • Thom D
        Variation in estimates of urinary incontinence prevalence in the community: Effects of definition, population characteristics, and study type.
        J Am Geriatr Soc. 1998; 46: 473-480
        • Carter BL
        • Malone DC
        • Valuck RJ
        • et al.
        The IMPROVE Study: Background and study design.
        Am J Health-Syst Pharm. 1998; 55: 62-67
      1. AHFS 98 Drug Information. American Society of Health-Systems Pharmacists, Inc, Bethesda, Md1998
      2. Drug Facts and Comparisons, January 1998. Facts and Comparisons, St. Louis, Mo1998
      3. Malone DC, Billups SJ, Valuck RJ, Carter BL. Development of a chronic disease indicator score using a Veterans Affairs medical center medication database. J Clin Epidemiol. In press.

        • Milner G
        • Hills NF
        A double-blind assessment of antidepressants in the treatment of 212 enuretic patients.
        Med J Aust. 1968; 1: 943-947
        • Castleden NS
        • Duffin HM
        • Gulati RS
        Double-blind study of imipramine and placebo for incontinence due to bladder instability.
        Age Ageing. 1986; 15: 299-303
        • Karram MM
        • Bhatia NN
        Management of coexistent stress and urge urinary incontinence.
        Obstet Gynecol. 1989; 73: 4-7
        • Appell RA
        Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis.
        Urology. 1997; 50: 90-96